The DNA damage pathway regulates innate immune system ligands of the NKG2D receptorMissing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptorsInhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice.Immune surveillance of unhealthy cells by natural killer cellsSelective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2DPositive selection of dendritic epidermal gammadelta T cell precursors in the fetal thymus determines expression of skin-homing receptorsA novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunityInnate or adaptive immunity? The example of natural killer cellsImpaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice.Immunosurveillance of senescent cancer cells by natural killer cellsDevelopment and tolerance of natural killer cells.Recombination signal sequence-associated restriction on TCRdelta gene rearrangement affects the development of tissue-specific gammadelta T cells.NKG2A inhibits invariant NKT cell activation in hepatic injury.Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formationExpression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation.The role of the NKG2D immunoreceptor in immune cell activation and natural killing.Mature natural killer cells reset their responsiveness when exposed to an altered MHC environmentComparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.Regulation of ligands for the NKG2D activating receptor.Infection-induced regulation of natural killer cells by macrophages and collagen at the lymph node subcapsular sinus.Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skinStress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase.RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphomaThe MHC reactivity of the T cell repertoire prior to positive and negative selection.Oncogenic stress sensed by the immune system: role of natural killer cell receptorsRecognition of tumors by the innate immune system and natural killer cells.ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cellsEndoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells.A simple and effective method for differentiating GFP and YFP by flow cytometry using the violet laser.The innate immune response to tumors and its role in the induction of T-cell immunity.Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition.Innate immune recognition by stimulatory immunoreceptors.The genomic arrangement of T cell receptor variable genes is a determinant of the developmental rearrangement pattern.Cytokine therapy reverses NK cell anergy in MHC-deficient tumorsNKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCTA subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2.Multiplicity and plasticity of natural killer cell signaling pathways.NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease.Interplay of natural killer cells and their receptors with the adaptive immune response.
P50
Q24306696-DDBF3F98-ECB3-46F1-B14D-0BC96BDF53EEQ24633504-0F6B23D6-9D54-4232-9512-04D55850D382Q24817190-FFA97067-9076-4B4E-A37D-C966E34BC362Q27003079-8E94B7EE-637B-48A5-9A99-46AF1929016BQ28214530-DA422088-1F58-409C-B4F2-AE7571DD3721Q28508068-A7FCAB3F-9940-43CC-88F9-C8A272313A56Q28510660-DB3E6D9B-72FA-4FFE-A080-A439FF91FFB1Q29615106-1DCE1C63-63C5-454E-BBBD-4678F6469D05Q30413179-6E772830-61D3-433D-81E9-1C096F57442BQ33553537-5B9B43B0-93F4-41FA-8312-3E164F99EDDEQ33632405-94A7780A-6900-4E39-B205-0A135C4E7403Q33673299-C372BA13-6390-4AFF-8FB0-D02F5722AED3Q33739557-32FDD9AE-24EF-4487-8F36-8AC2CAB4E5C7Q33894585-456C9DBA-0E49-44FF-82D1-D5E87033ED3AQ34037679-CBE46FCD-153B-4817-8CBB-D1505CE94851Q34142062-940ABD83-1AB8-4F23-AB86-59CAF03C5870Q34161567-CF7908D6-63CB-4D21-85DE-8368BA27B9D1Q34309234-28A0AB66-9150-4632-8260-5E5ECB07F86BQ34321457-22DAF6B6-0B38-44AC-897D-4FA81D2A725CQ34354896-D87644D5-393C-4EDC-B3B6-AE19D8E51F24Q34402566-F5B03D95-F1F8-4CD9-9263-11FE2BE14FD3Q34402646-4F9A7982-9807-4869-A0FB-5C12AE03715AQ34407976-58B1A59A-900C-4923-89C1-A5F6BD7CB308Q34418401-6F2FB5B9-7A27-469C-AF83-CC713C26C692Q34473267-1C72CF20-F98C-4F47-B7C2-05DF42601FD2Q34496462-C30EFCC7-FD48-4F9C-AB59-5EB1D07DFAB8Q34660118-FE8F5447-092D-49BF-89EC-3BF2267B3B2BQ34921343-51ED4596-F650-47A6-A2FA-F1C57E8D29F4Q34983394-4E48B5D9-50B3-4DB6-9435-A45A01A46110Q35005908-D458CE7F-F67B-4A3F-947B-EACCF54E85CFQ35025354-743F18B5-FAE0-4096-8F6A-004EC6972665Q35031959-B8506BC0-5330-4DA6-959E-B723D55DAA67Q35122359-D8BE8007-545A-4D2A-8D8C-7FEE9FEA4DE5Q35140125-911485A3-9AF6-4F77-B22E-85C0CD353ABBQ35692428-33A13F16-7D32-4A46-9FAD-038A5DF23F43Q35847508-1B23470F-3150-431C-8FA9-C37C1671268AQ35847866-15C7289A-4319-44F9-800A-58C188CDA55FQ35849513-68246009-DA2C-432D-9627-B3792BBC46F4Q35903449-2CA872AB-6559-4979-AA07-8C6ED1529CB6Q35904393-CBCEA240-ADDF-4B63-8FDE-2D387607FFC1
P50
description
immunologist
@en
immunoloog
@nl
name
David H Raulet
@es
David H Raulet
@nl
David H. Raulet
@en
type
label
David H Raulet
@es
David H Raulet
@nl
David H. Raulet
@en
prefLabel
David H Raulet
@es
David H Raulet
@nl
David H. Raulet
@en
P214
P244
P106
P1153
7006111540
P21
P214
P244
n2006184514
P31
P496
0000-0002-1257-8649